max dose retatrutide Dosing Schedule: From Clinical Trials to Real Weight Loss Outcomes Retatrutide in adults with obesity

In oncology, Bristol Myers Squibbs iberdomide and mezigdomide aim to replace older myeloma therapies with next-generation oral CELMoDs

To manage the cost of either medication, its important to explore your options

What is included in the kit

Use the retatrutide dosage calculator to verify your specific numbers before each phase transition

Retatrutide 60mg is our maximum-strength research peptide vial, containing 60mg of the GIP/GLP-1/glucagon triple agonist Retatrutide as a lyophilised powder, for laboratory research use only

Research Overview Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously